Gender Male
John F. Dee joined Link in May, 2009. Previously, John served as President and Chief Executive Officer of Hypnion, Inc. from its founding in 2000 until its sale to Eli Lilly in 2007 for $325 million. Under his leadership, Hypnion raised approximately $70 million in venture capital, built a world-class scientific team and technology platform,
advanced 5 drugs into clinical trials, and positioned itself as the leader in sleep disorder research and development.
Prior to Hypnion, John spent a significant portion of his professional career with McKinsey & Co., Inc., where he conducted performance-improvement and strategic growth initiatives for several major energy and pharmaceutical companies. John has also served on several Boards of Directors and is currently a director of Verenium, Inc. In non-profit pursuits, John led a group of Bay Area economists and business leaders in an extensive public policy review of the San Francisco Bay Area's economic performance. John holds an M.S. in Engineering from Stanford University and an M.B.A. from Harvard University.
